Table 3.
Performance outcomes.
| Placebo (n = 6) |
CR (n = 7) |
||||
|---|---|---|---|---|---|
| Pre | Post | Pre | Post | p-value | |
| Avg Relative PPO (W)* | 8.4 ± 0.7 | 9.0 ± 0.7 | 8.7 ± 0.6 | 9.3 ± 0.8 | 0.907 |
| Avg Absolute PPO (W)* | 487.1 ± 62.3 | 520.8 ± 72.1 | 508.2 ± 76.6 | 543.9 ± 89.1 | 0.859 |
| Avg MPO (W)* | 426.2 ± 54.4 | 439.6 ± 58.5 | 429.2 ± 60.5 | 453.1 ± 65.8 | 0.208 |
| Avg FI (%)* | 25.4 ± 7.3 | 29.1 ± 7.5 | 29.0 ± 8.3 | 30.2 ± 6.6 | 0.370 |
| R Flexion Mean Peak Torque (Nm) | 57.4 ± 16.1 | 53.7 ± 11.4 | 56.8 ± 13.4 | 47.9 ± 8.3 | 0.476 |
| R Extension Mean Peak Torque (Nm) | 46.6 ± 10.8 | 39.5 ± 4.2 | 42.1 ± 9.0 | 40.6 ± 8.7 | 0.294 |
| L Flexion Mean Peak Torque (Nm)* | 58.5 ± 20.7 | 48.7 ± 11.7 | 56.4 ± 10.2 | 50.4 ± 7.5 | 0.461 |
| L Extension Mean Peak Torque (Nm)* | 40.1 ± 7.1 | 32.3 ± 4.7 | 40.2 ± 8.2 | 36.1 ± 9.4 | 0.448 |
| Vertical Jump Parallel (cm) | 36.2 ± 5.5 | 37.6 ± 4.2 | 34.1 ± 6.2 | 34.6 ± 6.4 | 0.541 |
| Vertical Jump 1st Position (cm) | 32.6 ± 6.2 | 33.4 ± 3.0 | 28.1 ± 6.0 | 29.4 ± 5.3 | 0.813 |
| Medicine Ball Throw (m) | 1.7 ± 0.2 | 1.8 ± 0.3 | 1.7 ± 0.4 | 1.7 ± 0.3 | 0.758 |
*Indicates a main effect of time regardless of treatment group (p ≤ 0.05) by paired t-tests.
CR; creatine monohydrate, PPO; peak power output, W; watts, MPO; mean power output FI; fatigue index %; percent, R; right, Nm; newton meters, L; left, cm; centimeters, m; meters.